EVALUATION OF KEMPTIDE, A SYNTHETIC SERINE-CONTAINING HEPTAPEPTIDE, AS A PHOSPHATE ACCEPTOR FOR THE ESTIMATION OF CYCLIC AMP-DEPENDENT PROTEIN-KINASE ACTIVITY IN RESPIRATORY TISSUES

被引:30
作者
GIEMBYCZ, MA [1 ]
DIAMOND, J [1 ]
机构
[1] UNIV BRITISH COLUMBIA,FAC PHARMACEUT SCI,DIV PHARMACOL & TOXICOL,VANCOUVER V6T 1W5,BC,CANADA
关键词
D O I
10.1016/0006-2952(90)90026-H
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the search for a phosphate acceptor to estimate cyclic AMP-dependent protein kinase (A-kinase) activity in respiratory tissues devoid of the disadvantages inherent with the use of histones, we compared and contrasted a conventional substrate, histone IIa, with that of a novel heptapeptide phosphate acceptor, Kemptide (Kemp et al., J Biol Chem 252: 4888-4894, 1977). The specific activities of soluble A-kinase isolated from guinea-pig lung parenchyma and from bovine tracheal smooth muscle were significantly (12-16-fold) greater when Kemptide was used as substrate when compared to histone IIa. Moreover, studies with a specific inhibitor of A-kinase demonstrated that whilst the cyclic AMP-stimulated phosphorylation of Kemptide was catalysed exclusively by A-kinase, only ~89% of the phosphate incorporated into histone IIa was attributed to the activity of this enzyme. The activation constant (Kact) of cyclic AMP for A-kinase was estimated to be 1.5 μM when Kemptide was used as substrate, 25-fold higher than that obtained using histone IIa (60 nM) under identical conditions. In a complementary series of experiments it was found that both the basal and isoprenaline-stimulated A-kinase activity ratios were significantly higher when histone IIa was used as substrate when compared with that obtained using Kemptide. Elevating the ionic strength of the homogenization buffer or assay cocktail with NaCl produced a reversible (following dialysis), concentration-dependent, mixed uncompetitive, inhibition of cyclic AMP-stimulated histone phosphorylation; phosphokemptide formation was unaffected. The ability of salt to inhibit A-kinase activity also affected the elution profile of A-kinase isoenzymes following their separation by DEAE-cellulose chromatography. With histone IIa as substrate the Type I: Type II isoenzyme ratio in guinea-pig lung and in bovine tracheal smooth muscle was 9:91 and 35:65, respectively. Changing the phosphate acceptor to Kemptide reduced these respective ratios to 5:95 and 29:71. Although the effect on the isoenzyme ratio was small, the specific activities of the two isoenzymes isolated from both tissues were markedly attentuated by ca. 9% (Type I) and 36% (Type II). It is concluded that Kemptide is without many of the disadvantages inherent with histone IIa and is, thus, a preferable phosphate acceptor for estimating soluble A-kinase activity and determining the isoenzyme ratio in guinea-pig lung and in bovine tracheal smooth muscle. © 1989.
引用
收藏
页码:271 / 283
页数:13
相关论文
共 31 条
[1]  
ASHBY CD, 1972, J BIOL CHEM, V247, P6637
[2]   ALTERATIONS OF PROTEIN-KINASE ISOZYMES IN TRANSPLANTABLE HUMAN-LUNG CANCER WITH SPECIAL REFERENCE TO THE PHOSPHORYLATION OF ARYLSULFATASE-B [J].
BALBAA, M ;
GASA, S ;
MAKITA, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 150 (01) :163-169
[3]   ACTIVATION OF PROTEIN KINASE BY PHYSIOLOGICAL CONCENTRATIONS OF CYCLIC-AMP [J].
BEAVO, JA ;
BECHTEL, PJ ;
KREBS, EG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (09) :3580-3583
[4]  
CHENG HC, 1986, J BIOL CHEM, V261, P989
[5]  
CHERRINGTON AD, 1976, J BIOL CHEM, V251, P5209
[6]   ADENOSINE CYCLIC 3',5'-MONOPHOSPHATE DEPENDENT PROTEIN-KINASE - KINETIC MECHANISM FOR THE BOVINE SKELETAL-MUSCLE CATALYTIC SUBUNIT [J].
COOK, PF ;
NEVILLE, ME ;
VRANA, KE ;
HARTL, FT ;
ROSKOSKI, R .
BIOCHEMISTRY, 1982, 21 (23) :5794-5799
[7]  
CORBIN JD, 1975, J BIOL CHEM, V250, P218
[8]  
CORBIN JD, 1983, METHOD ENZYMOL, V99, P227
[9]   REGULATORY MECHANISMS IN THE CONTROL OF PROTEIN-KINASES [J].
FLOCKHART, DA ;
CORBIN, JD .
CRC CRITICAL REVIEWS IN BIOCHEMISTRY, 1982, 12 (02) :133-186
[10]  
GIEMBYCZ MA, UNPUB BIOCH PHARM